Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
GSK exclusive license agreement for HS-20093 with Hansoh Pharma
We advised GSK on the transaction
Auna exchange offer and consent solicitations
We advised the Auna on the transaction
Merit Medical Systems $747.5 million convertible senior notes offering
The 3% convertible senior notes are due 2029
Evolent Health $402.5 million convertible notes offering
The convertible notes are due 2029
Innovent Biologics HK$2.4 billion placement of shares
The shares are listed on the Hong Kong Stock Exchange
Option Care Health $400 million revolving credit facility
We advised the administrative agent, joint lead arranger and joint bookrunner on the facility
Atara Biotherapeutics $100 million at-the-market offering
The stock is listed on Nasdaq
Smith+Nephew acquisition of CartiHeal
We are advising Smith+Nephew on the acquisition
WuXi XDC Cayman HK$3.68 billion IPO
The shares are listed on the HKEX
Amneal Pharmaceuticals $2.35 billion term loan
We advised Amneal Pharmaceuticals on a new term loan